Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The study will assess the efficacy of EP2006 compared to Filgrastim with respect to the mean
duration of severe neutropenia during treatment with myelosuppressive chemotherapy in breast
cancer patients.